Avalon enters distribution agreement with Saga Health for KetoAir

Avalon (ALBT) GloboCare announced that its subsidiary, Q&A Distribution, LLC, has entered into a wholesale distribution agreement with Saga Health Corporation for its use of the KetoAir breathalyzer device in its first responder-targeted Holistic Health Reset Program. “We believe that this agreement with Saga Health marks a milestone in accelerating the commercial expansion of KetoAir,” said David Jin, M.D., Ph.D., President and Chief Executive Officer of Avalon GloboCare. “KetoAir(TM) is a unique, science-driven tool that supports the growing demand for personalized, real-time monitoring of BrAce, and is intended for those pursuing ketogenic lifestyles. We’re pleased to collaborate with our partner Saga Health to further our goal of accelerating the commercial expansion of the KetoAir(TM).”